ArticleBMC infectious diseases2026
Epidemiology of human papillomavirus among women living with HIV in rural Uganda: a retrospective cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPersistent human papillomavirus (HPV) infection is a significant precursor to cervical abnormalities and invasive cancer. While the causal relationship between specific HPV types and cervical cancer is established, little is known about the distribution of HPV types among women living with HIV (WLWH) in Uganda. We aimed to describe the epidemiology of HPV types among women living with HIV at Mityana and Kiboga Hospitals in rural central Uganda.
methodsA retrospective review of demographic and clinical data, including age and antiretroviral therapy (ART) history, was conducted among WLWH tested for HPV between July 2021 and July 2022. GeneXpert HPV DNA real-time Polymerase Chain Reaction assay (RT-PCR) detected HPV 16, 18/45, and other pooled high-risk types (31, 33, 35, 39, 51, 52, 56, 58, 59, 66, and 68). HPV infections were categorized into single and multiple subtypes. Statistical analysis involved Chi-square tests and modified Poisson regression with robust standard error models to evaluate associations and identify factors linked with HPV infection.
resultsAmong 1305 WLWH, the overall prevalence of HPV infection was 39.1%. HPV16 and HPV18/45 were the most common genotypes, with a prevalence of 8.1% and 8.2%, respectively. Multiple HPV infections were observed in 18.4% of cases, with combinations of HPV 16, HPV 18/45, and other high-risk HPV types. Increasing age was significantly associated with a lower prevalence of HPV infection (PR = 0.97; 95% CI: 0.95-0.99; p = 0.003).
conclusionA high prevalence of genital high-risk HPV infection was observed among WLWH attending ART clinics in public health facilities in Uganda. Other high-risk HPV types were the most frequently detected, compared to HPV18/45 and HPV16. The high prevalence of high-risk HPV among WLWH, particularly among younger age groups, highlights the need to integrate HPV screening within routine HIV care services and to strengthen targeted prevention strategies, including vaccination and early screening in rural settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.